Phibro Animal Health (PAHC) Income from Continuing Operations (2012 - 2026)
Phibro Animal Health (PAHC) posted quarterly Income from Continuing Operations of 24024000.0 for Q1 2026, up 15.06% year-over-year from 20880000.0 in Q1 2025, and down 12.51% quarter-over-quarter from 27459000.0 in Q4 2025.
Phibro Animal Health (PAHC) Income from Continuing Operations (2012 - 2026) Analysis & Trends
Phibro Animal Health's Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 24024000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 15.06% year-over-year to 24024000.0; the TTM figure through Mar 2026 stood at 95234000.0 (up 783.22% YoY), while the FY2025 annual figure was 48264000.0, up 211.43% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 24024000.0, down from 27459000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 27459000.0 in Q4 2025, with the low at 44979000.0 in Q2 2024.
- The 5-year median for Income from Continuing Operations is 8405000.0 (2024), against an average of 8278882.35.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations slumped 491.19% in 2024, then surged 762.14% in 2025.
- Phibro Animal Health's Income from Continuing Operations stood at 7210000.0 in 2022, then slumped by 82.33% to 1274000.0 in 2023, then soared by 150.0% to 3185000.0 in 2024, then surged by 762.14% to 27459000.0 in 2025, then declined by 12.51% to 24024000.0 in 2026.
- Business Quant data shows PAHC's Income from Continuing Operations at 24024000.0 in Q1 2026, 27459000.0 in Q4 2025, and 26527000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 24.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.02 Mn |
| Dec 31, 2025 | 27.46 Mn |
| Sep 30, 2025 | 26.53 Mn |
| Jun 30, 2025 | 17.22 Mn |
| Mar 31, 2025 | 20.88 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | -44.98 Mn |
| Mar 31, 2024 | 8.41 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | -8.02 Mn |
| Jun 30, 2023 | 11.50 Mn |
| Mar 31, 2023 | 10.04 Mn |
| Dec 31, 2022 | 7.21 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 7.49 Mn |
| Mar 31, 2022 | 17.69 Mn |
| Dec 31, 2021 | 17.47 Mn |
| Sep 30, 2021 | 6.53 Mn |
| Jun 30, 2021 | 14.94 Mn |